Duncan Gilmour
Analyst · Lake Street Capital Markets
Thank you, Rich. Starting on Slide 6. On a sequential basis, revenue in Q3 was essentially flat, down $0.2 million from $35.3 million in Q2 to $35.1 million. Higher Defense/Aerospace, Semi, Industrial and other revenue largely offset a $6.8 million decline in Auto/EV following Q2's shipment of high revenue, lower-margin Auto/EV projects from backlog. Defense/Aerospace increased $3.6 million, Semi increased $2.5 million, Industrial contributed $0.8 million and other contributed $0.7 million. Partially offsetting these gains, in addition to the Auto/EV decline, was a $0.8 million decrease in Life Sciences. Compared to Q3 2025, revenue increased $8.8 million or 34% from $26.2 million. The net increase was driven by Defense/Aerospace, which more than tripled on higher program activity, together with growth in Auto/EV, Semi and Industrial. Together, these 4 markets contributed $9.9 million of growth, which more than absorbed declines in Life Sciences and Safety/Security. Turning to Slide 7. Q3 gross profit was $16.7 million, up 52% year-over-year and gross margin was 47.7%. Sequentially, gross margin expanded by 720 basis points from 40.5%, reflecting a large positive shift in product mix. Compared with the prior year period, gross margin increased by 580 basis points from 41.9%, reflecting the same positive shift in mix. Moving on to Slide 8. Operating expenses for the third quarter were $14 million, up $0.1 million sequentially as higher general and administrative expenses were largely offset by lower amortization of intangibles. On a year-over-year basis, we generated $8.8 million of incremental revenue while absorbing only $1.8 million of incremental operating expenses. This reduced operating expenses as a percentage of revenue to 39.9% from 46.4% in the prior year period. The $1.8 million or 14.8% increase reflects higher selling, general and administrative and engineering expenses, primarily higher payroll and payroll-related costs and higher commissions associated with higher volume, partially offset by lower amortization and restructuring costs. Slides 9 and 10 collectively measure our profitability. On Slide 9, net margin expanded by 400 basis points sequentially and 890 basis points year-over-year to 5.3% and adjusted EBITDA margin expanded by 640 basis points sequentially and over 1,000 basis points year-over-year to 12.6%. For Q3, net earnings were $1.9 million compared with $0.5 million in the second quarter and a net loss of $0.9 million in Q3 2025. Adjusted EBITDA was $4.4 million, up from $2.2 million in the second quarter and $0.4 million in Q3 2025. On Slide 10, net earnings were $0.15 per diluted share compared with a net loss of $0.08 per diluted share in the prior year period. Adjusted EPS, which adds back tax-affected acquired intangible amortization and restructuring charges, was $0.18 per diluted share compared with an adjusted net loss of $0.02 per diluted share in Q3 2025. One item to note since it affected per share results this quarter is on the tax line. Our effective tax rate in Q3 was approximately 30%. This brings our year-to-date tax rate up to an increased expected full-year rate of approximately 20%, including the discrete benefit recorded in Q2. The higher expected rate is driven by a higher proportion of profitability being generated in our higher tax jurisdictions. Slide 11 shows our capital structure and cash flow. We ended Q3 with cash and cash equivalents of $20.9 million, a decline of $1.2 million from the end of Q2. Operating activities used $0.3 million of cash in the quarter. Net earnings and noncash charges contributed approximately $4.4 million, which was more than offset by a $3.6 million increase in accounts receivable and a $1 million reduction in customer deposits and deferred revenue. After $0.4 million of capital expenditures, free cash flow was negative $0.6 million. We also reduced term debt by $1 million during the quarter. At September 30, 2026, we had approximately $61 million in total liquidity, including $20.9 million of cash and equivalents and $40 million of available borrowing capacity, consisting of $30 million under our delayed draw term loan facility and a full $10 million under our undrawn revolving credit facility. On August 14, we amended the facility to extend our ability to draw on the term note through August 28, 2028. Total debt was $5.5 million, and our leverage ratio was 0.5x trailing 12-month adjusted EBITDA. We were in compliance with all covenants at quarter end. Turning to Slide 12 and our financial guidance. Q3 came in at or better than our August guidance on revenue, gross margin and operating expenses. Our Q4 guidance maintains a steady incremental progression with 2 factors to keep in mind. First, Q3's product mix was particularly favorable. Second, we expect some modest expense increases in Q4 as we fill open leadership positions and start planning for 2027. Looking beyond Q4, we are positioned for a solid start to 2027. Our record backlog, roughly 60% of which ships in 2027, together with Q3 semiconductor orders converting largely in the first half supports that outlook. We will provide full year '27 guidance with our fourth quarter results as is our practice. For Q4, we project revenue of $34 million to $36 million, gross margin of approximately 45%, operating expenses of $14.2 million to $14.7 million and within operating expenses, amortization of $0.5 million. This guidance excludes any potential acquisitions and restructuring and restructuring-related costs and assumes our view of macroeconomic conditions remains unchanged through the end of the year. One housekeeping note. After the market closes today, we intend to file our Form 10-Q. We will also file a Form S-3 to refresh our existing shelf registration before it expires. Now if you turn to Slide 13, I will turn the call back over to Rich. Rich?